Tactile Systems Technology Inc (TCMD) Director Sells $245,350.00 in Stock
Tactile Systems Technology Inc (NASDAQ:TCMD) Director Kevin H. Roche sold 4,907 shares of the firm’s stock in a transaction that occurred on Thursday, May 30th. The shares were sold at an average price of $50.00, for a total value of $245,350.00. Following the completion of the transaction, the director now owns 40,311 shares in the company, valued at approximately $2,015,550. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.
Tactile Systems Technology stock traded up $1.49 during trading on Monday, reaching $49.52. 190,404 shares of the company were exchanged, compared to its average volume of 285,971. Tactile Systems Technology Inc has a 52-week low of $37.40 and a 52-week high of $76.63. The company has a market cap of $911.37 million, a price-to-earnings ratio of 145.47, a PEG ratio of 4.84 and a beta of 1.96. The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.30 and a current ratio of 4.96.
Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings data on Monday, May 6th. The company reported $0.08 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.12) by $0.20. Tactile Systems Technology had a return on equity of 8.17% and a net margin of 5.27%. The firm had revenue of $37.60 million for the quarter, compared to the consensus estimate of $33.30 million. The business’s revenue was up 40.3% on a year-over-year basis. On average, analysts predict that Tactile Systems Technology Inc will post 0.5 EPS for the current fiscal year.
Several research firms have recently weighed in on TCMD. BidaskClub downgraded Tactile Systems Technology from a “hold” rating to a “sell” rating in a research report on Friday, May 24th. ValuEngine downgraded Tactile Systems Technology from a “buy” rating to a “hold” rating in a research report on Tuesday, May 14th. Zacks Investment Research upgraded Tactile Systems Technology from a “hold” rating to a “buy” rating and set a $65.00 target price on the stock in a research report on Saturday, May 11th. Guggenheim raised their target price on Tactile Systems Technology from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, May 7th. Finally, Piper Jaffray Companies raised their target price on Tactile Systems Technology to $84.00 and gave the company an “overweight” rating in a research report on Monday, May 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $75.80.
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices for the treatment of chronic diseases in the United States. The company offers Flexitouch system, an at-home solution for lymphedema patients; and ACTitouch system, a home-based solution for chronic venous insufficiency patients.
See Also: What is total return in investing?
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.